Stock Researching
Vivus Signed Marketing Deal with Auxilium Pharmaceuticals
Stock Researching
Publish date: Sat, 19 Oct 2013, 05:53 AM
Stock Researching
0 251,658
Stockresearching is a blog designed to help the independent investor create new ideas and receive valuable informed information.
From Liston Street Pulse:
Vivus Inc. (VVUS) has recently announced that the company signed a marketing deal with Auxilium Pharmaceuticals. The deal is for Auxilium Pharmaceuticals to market Vivus' erectile dysfunction drug, Stendra, in the US. Stendra has already been approved in the US since April of last year. However the company's main focus […]
The post Vivus Signed Marketing Deal with Auxilium Pharmaceuticals appeared first on Liston Street Pulse.
More articles on Stock Researching
Enbridge Inc: 2016 Fundamental Analysis WACC, Cost of Debt and Cost of Equity $ENB
Created by Stock Researching | Dec 13, 2016
Apple Inc: Fundamental Analysis WACC, Cost of Debt and Cost of Equity $AAPL
Created by Stock Researching | Dec 04, 2016
Visa Inc: Fundamental Analysis WACC, Cost of Debt and Cost of Equity $V
Created by Stock Researching | Dec 02, 2016
Telus Corp. Cost of Debt, CAPM, WACC and Valuation $TU, $T.TO
Created by Stock Researching | Nov 19, 2016
Assessing Canadian Telecom Exposure, $BCE is worth a look
Created by Stock Researching | Nov 10, 2016
$UPS Deriving Value From E-Commerce Growth And Lower Energy Prices
Created by Stock Researching | Oct 05, 2015
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
Tech Giants Brace for AI Revamp, Antitrust Pullback in Trump 2.0
2
CEO Morning Brief
Nvidia Rides AI Wave to Pass Apple as World’s Largest Company Again
3
CEO Morning Brief
Fed to Cut Rates, But With a New Landscape to Decipher After Trump Win
4
CEO Morning Brief
The Bull Market in US Stocks Is Just Starting, Evercore Says
5
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
